Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-004086

Options or other derivatives

  • Cheif Executive Officer acquired 306,366 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · Cheif Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-15 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +306,366 306,366 D
Loading xslF345X03/wf-form4_167667149838499.xml…